Epigenetics in type 1 diabetes: TNFa gene promoter methylation status in Chilean patients with type 1 diabetes mellitus

British Journal of Nutrition

Volumn 116, Issue 11, 2016, Pages 1861-1868

  Arroyo Jousse, Viviana ^a   Garcia Diaz, Diego F ^a   Codner, Ethel ^a   Pérez Bravo, Francisco ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Epigenetics; Homocysteine; Methylation; TNF ; Type 1 diabetes

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; TNF PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHILEAN; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; EPIGENETICS; FEMALE; FOLIC ACID BLOOD LEVEL; GENE EXPRESSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TNF ALPHA GENE; ADOLESCENT; BLOOD; BODY MASS; CHEMISTRY; CHILD; CHILDHOOD OBESITY; CHILE; COMPLICATION; DNA DENATURATION; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; METABOLISM; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILE; DIABETES MELLITUS, TYPE 1; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; NUCLEIC ACID DENATURATION; PEDIATRIC OBESITY; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84997848545     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516003846     Document Type: Article

References (46)

1. Pugliese A (2013) The multiple origins of type 1 diabetes. Diabet Med 30, 135-146.
2. Redondo MJ & Eisenbarth GS (2002) Genetic control of autoimmunity in type I diabetes and associated disorders. Diabetologia 45, 605-622.
3. Adeghate E, Schattner P & Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 1084, 1-29.
4. Hermann R, Knip M, Veijola R, et al. (2003) Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia 46, 420-425.
5. Fourlanos S, Varney MD, Tait BD, et al. (2008) The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31, 1546-1549.
6. Hewagama A & Richardson B (2009) The genetics and epigenetics of autoimmune diseases. J Autoimmun 33, 3-11.
7. Anderson OS, Sant KE & Dolinoy DC (2012) Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem23, 853-859.
8. Nazki FH, Sameer AS & Ganaie BA (2014) Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 533, 11-20.
9. Devaraj S, Glaser N, Griffen S, et al. (2006) Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55, 774-779.
10. Grunnet LG, Aikin R, Tonnesen MF, et al. (2009) Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes 58, 1807-1815.
11. Rabinovitch A & Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulindependent diabetes mellitus. Biochem Pharmacol 55, 1139-1149.
12. Sullivan KE, Reddy AB, Dietzmann K, et al. (2007) Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 27, 5147-5160.
13. Sharples AP, Polydorou I, Hughes DC, et al. (2016) Skeletal muscle cells possess a 'memory' of acute early life TNF-alpha exposure: role of epigenetic adaptation. Biogerontology 17, 603-617.
14. Campion J, Milagro FI, Goyenechea E, et al. (2009) TNF-alpha promoter methylation as a predictive biomarker for weightloss response. Obesity (Silver Spring) 17, 1293-1297.
15. Gomez-Uriz AM, Goyenechea E, Campion J, et al. (2014) Epigenetic patterns of two gene promoters (TNF-alpha and PON) in stroke considering obesity condition and dietary intake. J Physiol Biochem 70, 603-614.
16. Hermsdorff HH, Mansego ML, Campion J, et al. (2013) TNF-alpha promoter methylation in peripheral white blood cells: relationship with circulating TNFalpha, truncal fat and n-6 PUFA intake in young women. Cytokine 64, 265-271.
17. Arroyo-Jousse V, Garcia-Diaz DF & Perez-Bravo F (2015) [Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients]. Rev Med Chil 143, 562-568.
18. Diaz-Valencia PA, Bougneres P & Valleron AJ (2015) Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 15, 255.
19. Jones TG, Warber KD & Roberts BD (2010) Analysis of hemoglobin A1c from dried blood spot samples with the Tina-quantR II immunoturbidimetric method. J Diabetes Sci Technol 4, 244-249.
20. Frantzen F, Faaren AL, Alfheim I, et al. (1998) Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44, 311-316.
21. Owens JE, Holstege DM & Clifford AJ (2005) Quantitation of total folate in whole blood using LC-MS/MS. J Agric Food Chem 53, 7390-7394.
22. Smith E, Jones ME & Drew PA (2009) Quantitation of DNA methylation by melt curve analysis. BMC Cancer 9, 123.
23. Takai D & Jones PA (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 99, 3740-3745.
24. Eckhardt F, Lewin J, Cortese R, et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38, 1378-1385.
25. Kojima A, Kobayashi T, Ito S, et al. (2015) Tumor necrosis factor-alpha gene promoter methylation in Japanese adults with chronic periodontitis and rheumatoid arthritis. J Periodontal Res 51, 350-358.
26. Li Y, Zhao M, Hou C, et al. (2011) Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults. Diabetes Res Clin Pract 94, 242-248.
27. Bell CG, Teschendorff AE, Rakyan VK, et al. (2010) Genomewide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 3, 33.
28. Agardh E, Lundstig A, Perfilyev A, et al. (2015) Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. BMC Med 13, 182.
29. Kramer B, Meichle A, Hensel G, et al. (1994) Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim Biophys Acta 1219, 413-421.
30. Economou JS, Rhoades K, Essner R, et al. (1989) Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med 170, 321-326.
31. Comb M & Goodman HM (1990) CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18, 3975-3982.
32. Clark SJ, Harrison J & Molloy PL (1997) Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 195, 67-71.
33. Iguchi-Ariga SM & Schaffner W (1989) CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 3, 612-619.
34. Weber M, Davies JJ, Wittig D, et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37, 853-862.
35. Zelova H & Hosek J (2013) TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflamm Res 62, 641-651.
36. Ma J, Dempsey AA, Stamatiou D, et al. (2007) Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects. Atherosclerosis 191, 63-72.
37. Wettinger SB, Doggen CJ, Spek CA, et al. (2005) High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood 105, 2000-2006.
38. Lokk K, Modhukur V, Rajashekar B, et al. (2014) DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol 15, r54.
39. Gowers IR, Walters K, Kiss-Toth E, et al. (2011) Age-related loss of CpG methylation in the tumour necrosis factor promoter. Cytokine 56, 792-797.
40. Finkelstein JD (1998) The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157, Suppl. 2, S40-S44.
41. Williams KT & Schalinske KL (2007) New insights into the regulation of methyl group and homocysteine metabolism. J Nutr 137, 311-314.
42. Jacobs RL, House JD, Brosnan ME, et al. (1998) Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 47, 1967-1970.
43. Nieman KM & Schalinske KL (2011) Insulin administration abrogates perturbation of methyl group and homocysteine metabolism in streptozotocin-treated type 1 diabetic rats. Am J Physiol Endocrinol Metab 301, E560-E565.
44. Abu-Lebdeh HS, Barazzoni R, Meek SE, et al. (2006) Effects of insulin deprivation and treatment on homocysteine metabolism in people with type 1 diabetes. J Clin Endocrinol Metab 91, 3344-3348.
45. Williams KT, Garrow TA & Schalinske KL (2008) Type I diabetes leads to tissue-specific DNA hypomethylation in male rats. J Nutr 138, 2064-2069.
46. Kurdyukov S & Bullock M (2016) DNA methylation analysis: choosing the right method. Biology (Basel) 5, 1-21.